Stock CADL CANDEL THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Candel Therapeutics, Inc.

Equities

CADL

US1374041093

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-28 pm EDT 		5-day change 1st Jan Change
8.55 USD +9.62% Intraday chart for Candel Therapeutics, Inc. -28.63% +481.63%
May. 23 Candel Therapeutics Reports Prolonged Overall Survival in Phase 2 Clinical Trial of Can-2409 for Advanced Non-Small Cell Lung Cancer in Patients Non-Responsive to Immune Checkpoint Inhibitor Treatment At 2024 Asco Annual Meeting CI
Apr. 11 Sector Update: Health Care Stocks Decline Thursday Afternoon MT

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
CANDEL THERAPEUTICS, INC.
Other Biotechnology & Medical Research
+9.62%-28.63%+481.63%+489.66% - 229M
Neutral
Bullish
Bullish
  1. Stock Market
  2. Equities
  3. CADL Stock
  4. Charts Candel Therapeutics, Inc.
  5. Relative Strength Chart